J. Parkin

Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.

A. Cowman, J. Zalcberg, P. Kantharidis, 1995, British Journal of Cancer.

Clinical application of a rapid, functional assay for multidrug resistance based on accumulation of the fluorescent dye, fluo-3.

I. Marschner, J. Zalcberg, R. Sparrow, 1993, European journal of cancer.

MRP1 not MDR1 gene expression is the predominant mechanism of acquired multidrug resistance in two prostate carcinoma cell lines

J. Zalcberg, P. Kantharidis, J. Parisot, 2000, Prostate Cancer and Prostatic Diseases.

Inheritance of chromosome 7 is associated with a drug-resistant phenotype in somatic cell hybrids.

M. de Silva, L. Campbell, J. Zalcberg, 1996, British Journal of Cancer.

Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia.

J. Zalcberg, D. Rischin, P. Kantharidis, 1999, Blood.

Cyclosporin A and PSC 833 prevent up-regulation of MDR1 expression by anthracyclines in a human multidrug-resistant cell line.

J. Zalcberg, P. Kantharidis, X. Hu, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.

J. Zalcberg, A. El-Osta, P. Kantharidis, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line

J. Zalcberg, D. Rischin, P. Kantharidis, 1999, British Journal of Cancer.

Expression of mdr1 and mrp in the normal B‐cell homologue of B‐cell chronic lymphocytic leukaemia

J. Zalcberg, P. Kantharidis, D. Tzelepis, 1997, British journal of haematology.

Rapid functional assay for multidrug resistance in human tumor cell lines using the fluorescent indicator fluo-3.

J. Zalcberg, X. Hu, D. Wall, 1991, Journal of the National Cancer Institute.